The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SPH SINCLAIR IS PHARMA PLC ORD 1P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
15:54 27-Apr-2015 SPH Holding(s) in Company RNS -
07:00 27-Apr-2015 SPH FDA Approval for Silhouette Instalift RNS -
14:02 14-Apr-2015 SPH Form 8.3 - Sinclair IS pharma plc BZN +4.33% Up
11:23 01-Apr-2015 SPH Form 8.3 - Sinclair IS Pharma Plc. BZN -0.22% Down
10:42 27-Mar-2015 SPH Form 8.3 - Sinclair IS Pharma plc BZN +2.10% Up
11:24 26-Mar-2015 SPH Form 8.3 - Sinclair IS Pharma Plc BZN +2.37% Up
12:23 25-Mar-2015 SPH Form 8.3 - Sinclair IS Pharma plc BZN +2.79% Up
12:27 18-Mar-2015 SPH Form 8.3 - Sinclair IS Pharma Plc BZN +1.89% Up
07:00 17-Feb-2015 SPH Interim Results RNS -5.57% Down
07:01 27-Jan-2015 SPH Trading Statement RNS +0.14% Up
18:28 09-Jan-2015 SPH Posting of an updated investor presentation RNS +6.12% Up
08:27 10-Dec-2014 SPH Stuart Swanson - Form 8.3 - Sinclair IS Pharma plc RNS -5.39% Down
09:50 02-Dec-2014 SPH Form 8 (OPD) - Sinclair IS Pharma plc RNS -2.53% Down
15:56 25-Nov-2014 SPH Appointment of General Counsel RNS +17.74% Up
13:57 25-Nov-2014 SPH Form 8.3 - Sinclair IS Pharma plc BZN +17.74% Up
12:11 25-Nov-2014 SPH Result of AGM RNS +17.74% Up
07:00 25-Nov-2014 SPH Statement re AGM and commencement of offer period RNS +17.74% Up
15:41 20-Nov-2014 SPH Holding(s) in Company RNS +15.68% Up
15:34 20-Nov-2014 SPH Holding(s) in Company RNS +15.68% Up
15:20 19-Nov-2014 SPH Holding(s) in Company RNS +14.73% Up

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.

Market

Company Information
Updated Monthly
Company address 1st Floor, Whitfield Court, 30-32 Whitfield Street, London, W1T 2RQ, United Kingdom
Company website http://www.sinclairisph...
Market cap(in millions)* £ 227.57
Listing/Admission to trading 06 Jun 2011
Trading service -
Market -
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
02-Aug-15
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



SINCLAIR IS PHA share - news analysis